These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 7732823)

  • 1. Properties of LTA4 synthase in human neutrophil preparations.
    Hill E; MacMillan D; Sala A; Henson PM; Murphy RC
    Adv Prostaglandin Thromboxane Leukot Res; 1995; 23():155-7. PubMed ID: 7732823
    [No Abstract]   [Full Text] [Related]  

  • 2. Eosinophil 15-lipoxygenase is a leukotriene A4 synthase.
    MacMillan DK; Hill E; Sala A; Sigal E; Shuman T; Henson PM; Murphy RC
    J Biol Chem; 1994 Oct; 269(43):26663-8. PubMed ID: 7929400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversible membrane association of neutrophil 5-lipoxygenase is accompanied by retention of activity and a change in substrate specificity.
    Hill E; Maclouf J; Murphy RC; Henson PM
    J Biol Chem; 1992 Nov; 267(31):22048-53. PubMed ID: 1429555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrinsic 5-lipoxygenase activity is required for neutrophil responsivity.
    Guidot DM; Repine MJ; Westcott JY; Repine JE
    Proc Natl Acad Sci U S A; 1994 Aug; 91(17):8156-9. PubMed ID: 8058773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A kinetic scheme of human neutrophil 5-lipoxygenase activity].
    Sud'ina GF; Kobel'kov GM; Barskiĭ OA; Varfolomeev SD
    Biokhimiia; 1990 Oct; 55(10):1795-811. PubMed ID: 1964097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Zileuton (A-64077) on the 5-lipoxygenase activity of human whole blood ex vivo.
    Sirois P; Borgeat P; Lauzière M; Dubé L; Rubin P; Kesterson J
    Agents Actions; 1991 Sep; 34(1-2):117-20. PubMed ID: 1665285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Irreversible inactivation of 5-lipoxygenase by leukotriene A4. Characterization of product inactivation with purified enzyme and intact leukocytes.
    Lepley RA; Fitzpatrick FA
    J Biol Chem; 1994 Jan; 269(4):2627-31. PubMed ID: 8300592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tenidap inhibits 5-lipoxygenase product formation in vitro, but this activity is not observed in three animal models.
    Carty TJ; Sweeney FJ; Griffiths RJ; Eskra JD; Ernest MJ; Pillar JS; Cheng JD; Loose LD; Joseph PA; Pazoles PP; Moore PF; Nagahisa A; Murase S; Kadin SB
    Inflamm Res; 1997 May; 46(5):168-79. PubMed ID: 9197987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacodynamic and pharmacokinetic characterisation of RBx 7796: a novel 5-lipoxygenase inhibitor.
    Shirumalla RK; Sharma P; Dastidar SG; Paliwal JK; Kakar S; Varshney B; Singh Saini G; Sattigeri V; Salman M; Ray A
    Inflamm Res; 2008 Mar; 57(3):135-43. PubMed ID: 18369577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of highly purified eicosapentaenoic acid in patients with psoriasis.
    Terano T; Kojima T; Seya A; Tanabe E; Hirai A; Makuta H; Ozawa A; Fujita T; Tamura Y; Okamoto S
    Adv Prostaglandin Thromboxane Leukot Res; 1989; 19():610-3. PubMed ID: 2546400
    [No Abstract]   [Full Text] [Related]  

  • 11. [Role of exogenous arachidonate in the biosynthesis of 5-lipoxygenase metabolites of arachidonic acid by human polymorphonuclear leukocytes induced by the calcium ionophore A23187].
    Sud'ina GF; Barskiĭ OA; Varfolomeev SD
    Biokhimiia; 1990 Sep; 55(9):1655-9. PubMed ID: 2127729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potent inhibitors of 5-lipoxygenase identified using pseudoreceptors.
    Rödl CB; Tanrikulu Y; Wisniewska JM; Proschak E; Schneider G; Steinhilber D; Hofmann B
    ChemMedChem; 2011 Jun; 6(6):1001-5. PubMed ID: 21506275
    [No Abstract]   [Full Text] [Related]  

  • 13. Activation of 5-lipoxygenase in whole polymorphonuclear leukocytes by arachidonic acid: evidence of cytosolic active enzyme.
    Vila L; Sola J
    Adv Exp Med Biol; 1997; 400A():47-56. PubMed ID: 9547536
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunohistochemical study on arachidonate 5-lipoxygenase of porcine leukocytes.
    Ueda N; Natsui K; Yamamoto S; Komatsu N; Watanabe K
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():21-4. PubMed ID: 1825541
    [No Abstract]   [Full Text] [Related]  

  • 15. Reversible, calcium-dependent membrane association of human leukocyte 5-lipoxygenase.
    Rouzer CA; Samuelsson B
    Proc Natl Acad Sci U S A; 1987 Nov; 84(21):7393-7. PubMed ID: 3118366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substituted chromenes as potent, orally active 5-lipoxygenase inhibitors.
    Satoh Y; Stanton JL; Hutchison AJ; Libby AH; Kowalski TJ; Lee WH; White DH; Kimble EF
    J Med Chem; 1993 Nov; 36(23):3580-94. PubMed ID: 8246226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of 5-lipoxygenase: development of hydroxamic acids and hydroxyureas as potential therapeutic agents.
    Salmon JA; Jackson WP; Garland LG
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():109-12. PubMed ID: 1847758
    [No Abstract]   [Full Text] [Related]  

  • 18. [The role of phospholipase A2, 5-lipoxygenase, and cyclooxygenase in activation of human neutrophil "oxygen burst": the modulating effect of osmolality of the medium].
    Kuchkina NV; Orlov SN; Chuchalin AG
    Biokhimiia; 1994 Jul; 59(7):1034-41. PubMed ID: 7948413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockade of cytosolic phospholipase A(2) and 5-lipoxygenase activation in neutrophils by a natural isoflavanquinone abruquinone A.
    Hsu MF; Chang LC; Chen SC; Kuo SC; Lee HY; Lu MC; Wang JP
    Eur J Pharmacol; 2008 Nov; 598(1-3):123-31. PubMed ID: 18834875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pyrrolo(2,3-c)quinolines and pyrrolo(3,4-d)quinolines--synthesis and investigation of lipoxygenase inhibition].
    Görlitzer K; Fabian J; Frohberg P; Drutkowski G
    Pharmazie; 2002 Apr; 57(4):243-9. PubMed ID: 11998442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.